Sagimet Biosciences (SGMT) Assets Average (2023 - 2026)

Sagimet Biosciences' Assets Average history runs 4 years deep, the most recent figure standing at $112.1 million for Q1 2026.

• In Q1 2026, Assets Average fell 26.82% year-over-year to $112.1 million; the TTM figure through Mar 2026 stood at $112.1 million (down 26.82% YoY), while the FY2025 annual figure was $138.4 million, up 7.69% from the prior year.
• Assets Average was $112.1 million for Q1 2026 at Sagimet Biosciences, down from $122.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $191.8 million in Q2 2024 to a low of $62.2 million in Q3 2023.
• Historically, Assets Average has averaged $137.4 million across 4 years, with a median of $141.8 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Assets Average surged 192.39% in 2024, then fell 26.93% in 2025.
• A 4-year view of Assets Average shows it stood at $99.8 million in 2023, then jumped by 67.82% to $167.5 million in 2024, then fell by 26.91% to $122.4 million in 2025, then declined by 8.43% to $112.1 million in 2026.
• The last three Assets Average figures came in at $112.1 million (Q1 2026), $122.4 million (Q4 2025), and $132.9 million (Q3 2025), per Business Quant data.